HEPATITIS-B-VIRUZIDE
European patent · EP3426245 · In force
Register entry
- Publication number
- EP3426245
- Application number
- EP17763810
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 6, 2017
- Published
- Jan 16, 2019
- Granted
- Dec 14, 2022
- Protection ends at the latest
- Mar 5, 2037
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C07D 213/81 (2006.01)C07D 309/08 (2006.01)C07D 313/04 (2006.01)C07D 317/72 (2006.01)A61K 31/42 (2006.01)A61K 31/416 (2006.01)A61P 31/20 (2006.01)C07D 261/20 (2006.01)
- Priority
- US 201662304671 P 07.03.2016US 201662337675 P 17.05.2016
- PCT application
- PCT/US2017/020853 06.03.2017
- PCT publication
- WO2017/155844 14.09.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Oct 25, 2023
Change
Published in Swissreg on 25.10.2023
- May 9, 2023
Address changed
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 09.05.2023
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Jan 23, 2023
Agent entered
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 23.01.2023
- Dec 14, 2022
Granted
Published in Swissreg on 14.12.2022
Parties
Inventor
Belmont, MA 02478, US
Sudbury, MA 01776, US
Belmont, MA 02478, US
Watertown, MA 02472, US
Wellesley, MA 02481, US
Newton, MA 02461, US
Andover, MA 01810, US
Lexington, MA 02421, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.